Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society Article

Contrera, Kevin J, Kansara, Sagar, Goyal, Neerav et al. (2025). Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society . JAMA Otolaryngology - Head and Neck Surgery, 151(6), 615-625. 10.1001/jamaoto.2025.0410

cited authors

  • Contrera, Kevin J; Kansara, Sagar; Goyal, Neerav; Mady, Leila J; Puram, Sidharth V; Young, Geoffrey D; Zandberg, Dan P; Uppaluri, Ravindra; Ferrarotto, Renatta; Holsinger, F Christopher; Ferris, Robert L; Wenig, Barry L; Curry, Joseph M

sustainable development goals

authors

publication date

  • June 1, 2025

published in

keywords

  • CANCER
  • INDUCTION CHEMOTHERAPY
  • LOCALLY ADVANCED HEAD
  • Life Sciences & Biomedicine
  • NIVOLUMAB
  • OPEN-LABEL
  • Otorhinolaryngology
  • PEMBROLIZUMAB
  • RECURRENT
  • RESPONSE CRITERIA
  • SINGLE-ARM
  • Science & Technology
  • Surgery
  • TRIAL

Digital Object Identifier (DOI)

publisher

  • AMER MEDICAL ASSOC

start page

  • 615

end page

  • 625

volume

  • 151

issue

  • 6